MedTrace Logo

Tissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) Patients

NCT01970930 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 131

Last updated 2018-01-19

No results posted yet for this study

Summary

The purpose of the study is to isolate and characterize stem cells of patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET) to find out why these cells are not working the way they should be and why they seem to be sensitive to regulatory factors in the blood, such as clotting.

Conditions

Interventions

PROCEDURE

Blood specimen

4 green top tube 40 cc of blood draw

Sponsors & Collaborators

Principal Investigators

  • Ronald Hoffman, MD · Icahn School of Medicine at Mount Sinai

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2016-06-02
Completion
2016-06-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01970930 on ClinicalTrials.gov